ニュートロン、ブロックからの復帰を発表。

We have partnered with @temaetfs for $LLY and $NOVO earnings’ week. Here is the $HRTS ETF’s CIO breaking down for the quarter of $LLY. Find out more about the $HRTS GLP-1 ETF here

Eli Lilly, $LLY, finished up over 9% today after reporting better than expected earnings. Unusual Whales has partnered with @Temaetfs, & their $HRTS ETF, the GLP-1 ETF, with exposure to $LLY and $NOVO. Learn more on $HRTS

Stocks to Watch Today: LLY, WBD, and AMAT

Unusual Whales has partnered with @Temaetfs , & their $HRTS ETF, the GLP-1 ETF, to give you the $LLY earnings. $LLY reported: - Revenue: of $11.3 billion, est: $10 billion - EPS: $3.92, est: $2.70 See $HRTS ETF for exposure to weight loss drug stocks

Eli Lilly and Company (LLY) Shines in Q2 with $11.30 B Revenue, 68% EPS Growth

Unusual Whales has partnered with @Temaetfs & their $HRTS, the GLP-1 ETF, for earnings of Eli Lilly, $LLY! $LLY has earnings tomorrow, with a 6.16% ($47.59) implied move, the largest in 8 quarters. See $HRTS ETF for exposure to weight loss drug stocks

Unusual Whales has partnered with @Temaetfs & their $HRTS, the GLP-1 ETF, for earnings of Eli Lilly, $LLY, & Novo Nordisk, $NOVO. $NOVO's expected revenue is $10.8 billion, previous $10.01 billion. See $HRTS ETF for exposure to weight loss drug stocks

Stocks to Watch Today: CCL, LLY, and DLTR

LLY vs NVO: Which One is Likely to Become a $1T Company First